Global Cell Therapy Market Survey and Trend Research 2018
Summary
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Cell Therapy Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 CELL THERAPY MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Dendreon (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Mesoblast (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Vericel (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 AlloCure (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Anterogen (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Anterogen (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Antibe Therapeutics (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Astellas Pharma (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Athersys (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Avita Medical (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 AxoGen (Company Overview, Sales Data etc.)
4.12 Bellicum Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 BioCardia (Company Overview, Sales Data etc.)
4.14 BIOCELLULAR THERAPIES (Company Overview, Sales Data etc.)
4.15 Biogen Idec (Company Overview, Sales Data etc.)
4.16 Bio-Tissue (Company Overview, Sales Data etc.)
4.17 BIOTIME (Company Overview, Sales Data etc.)
4.18 BioTissue Technologies (Company Overview, Sales Data etc.)
4.19 BrainStorm Cell Therapeutics (Company Overview, Sales Data etc.)
4.20 Bluebird Bio (Company Overview, Sales Data etc.)
4.21 Bone Therapeutics (Company Overview, Sales Data etc.)
4.22 Caladrius (Company Overview, Sales Data etc.)
4.23 Capricor Therapeutics (Company Overview, Sales Data etc.)
4.24 CellBioMed (Company Overview, Sales Data etc.)
4.25 Celgene (Company Overview, Sales Data etc.)
4.26 Cell Medica (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Cell Therapy Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 CELL THERAPY MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Dendreon (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Mesoblast (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Vericel (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 AlloCure (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Anterogen (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Anterogen (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Antibe Therapeutics (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Astellas Pharma (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Athersys (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Avita Medical (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 AxoGen (Company Overview, Sales Data etc.)
4.12 Bellicum Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 BioCardia (Company Overview, Sales Data etc.)
4.14 BIOCELLULAR THERAPIES (Company Overview, Sales Data etc.)
4.15 Biogen Idec (Company Overview, Sales Data etc.)
4.16 Bio-Tissue (Company Overview, Sales Data etc.)
4.17 BIOTIME (Company Overview, Sales Data etc.)
4.18 BioTissue Technologies (Company Overview, Sales Data etc.)
4.19 BrainStorm Cell Therapeutics (Company Overview, Sales Data etc.)
4.20 Bluebird Bio (Company Overview, Sales Data etc.)
4.21 Bone Therapeutics (Company Overview, Sales Data etc.)
4.22 Caladrius (Company Overview, Sales Data etc.)
4.23 Capricor Therapeutics (Company Overview, Sales Data etc.)
4.24 CellBioMed (Company Overview, Sales Data etc.)
4.25 Celgene (Company Overview, Sales Data etc.)
4.26 Cell Medica (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global Cell Therapy Market 2012-2017, by Type, in USD Million
Table Global Cell Therapy Market 2012-2017, by Type, in Volume
Table Global Cell Therapy Market Forecast 2018-2023, by Type, in USD Million
Table Global Cell Therapy Market Forecast 2018-2023, by Type, in Volume
Table Dendreon Overview List
Table Cell Therapy Business Operation of Dendreon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mesoblast Overview List
Table Cell Therapy Business Operation of Mesoblast (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vericel Overview List
Table Cell Therapy Business Operation of Vericel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AlloCure Overview List
Table Cell Therapy Business Operation of AlloCure (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Anterogen Overview List
Table Cell Therapy Business Operation of Anterogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Anterogen Overview List
Table Cell Therapy Business Operation of Anterogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Antibe Therapeutics Overview List
Table Cell Therapy Business Operation of Antibe Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Cell Therapy Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Athersys Overview List
Table Cell Therapy Business Operation of Athersys (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Avita Medical Overview List
Table Cell Therapy Business Operation of Avita Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AxoGen Overview List
Table Cell Therapy Business Operation of AxoGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bellicum Pharmaceuticals Overview List
Table Cell Therapy Business Operation of Bellicum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioCardia Overview List
Table Cell Therapy Business Operation of BioCardia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOCELLULAR THERAPIES Overview List
Table Cell Therapy Business Operation of BIOCELLULAR THERAPIES (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Overview List
Table Cell Therapy Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bio-Tissue Overview List
Table Cell Therapy Business Operation of Bio-Tissue (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOTIME Overview List
Table Cell Therapy Business Operation of BIOTIME (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioTissue Technologies Overview List
Table Cell Therapy Business Operation of BioTissue Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BrainStorm Cell Therapeutics Overview List
Table Cell Therapy Business Operation of BrainStorm Cell Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bluebird Bio Overview List
Table Cell Therapy Business Operation of Bluebird Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bone Therapeutics Overview List
Table Cell Therapy Business Operation of Bone Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Caladrius Overview List
Table Cell Therapy Business Operation of Caladrius (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Capricor Therapeutics Overview List
Table Cell Therapy Business Operation of Capricor Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CellBioMed Overview List
Table Cell Therapy Business Operation of CellBioMed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Cell Therapy Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cell Medica Overview List
Table Cell Therapy Business Operation of Cell Medica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Cell Therapy Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Cell Therapy Sales Revenue Share, by Companies, in USD Million
Table Global Cell Therapy Sales Volume 2012-2017, by Companies, in Volume
Table Global Cell Therapy Sales Revenue Share, by Companies in 2017, in Volume
Table Cell Therapy Demand 2012-2017, by Application, in USD Million
Table Cell Therapy Demand 2012-2017, by Application, in Volume
Table Cell Therapy Demand Forecast 2018-2023, by Application, in USD Million
Table Cell Therapy Demand Forecast 2018-2023, by Application, in Volume
Table Global Cell Therapy Market 2012-2017, by Region, in USD Million
Table Global Cell Therapy Market 2012-2017, by Region, in Volume
Table Cell Therapy Market Forecast 2018-2023, by Region, in USD Million
Table Cell Therapy Market Forecast 2018-2023, by Region, in Volume
Table Global Cell Therapy Market 2012-2017, by Type, in USD Million
Table Global Cell Therapy Market 2012-2017, by Type, in Volume
Table Global Cell Therapy Market Forecast 2018-2023, by Type, in USD Million
Table Global Cell Therapy Market Forecast 2018-2023, by Type, in Volume
Table Dendreon Overview List
Table Cell Therapy Business Operation of Dendreon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mesoblast Overview List
Table Cell Therapy Business Operation of Mesoblast (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vericel Overview List
Table Cell Therapy Business Operation of Vericel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AlloCure Overview List
Table Cell Therapy Business Operation of AlloCure (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Anterogen Overview List
Table Cell Therapy Business Operation of Anterogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Anterogen Overview List
Table Cell Therapy Business Operation of Anterogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Antibe Therapeutics Overview List
Table Cell Therapy Business Operation of Antibe Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Cell Therapy Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Athersys Overview List
Table Cell Therapy Business Operation of Athersys (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Avita Medical Overview List
Table Cell Therapy Business Operation of Avita Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AxoGen Overview List
Table Cell Therapy Business Operation of AxoGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bellicum Pharmaceuticals Overview List
Table Cell Therapy Business Operation of Bellicum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioCardia Overview List
Table Cell Therapy Business Operation of BioCardia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOCELLULAR THERAPIES Overview List
Table Cell Therapy Business Operation of BIOCELLULAR THERAPIES (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Overview List
Table Cell Therapy Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bio-Tissue Overview List
Table Cell Therapy Business Operation of Bio-Tissue (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOTIME Overview List
Table Cell Therapy Business Operation of BIOTIME (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioTissue Technologies Overview List
Table Cell Therapy Business Operation of BioTissue Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BrainStorm Cell Therapeutics Overview List
Table Cell Therapy Business Operation of BrainStorm Cell Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bluebird Bio Overview List
Table Cell Therapy Business Operation of Bluebird Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bone Therapeutics Overview List
Table Cell Therapy Business Operation of Bone Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Caladrius Overview List
Table Cell Therapy Business Operation of Caladrius (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Capricor Therapeutics Overview List
Table Cell Therapy Business Operation of Capricor Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CellBioMed Overview List
Table Cell Therapy Business Operation of CellBioMed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Cell Therapy Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cell Medica Overview List
Table Cell Therapy Business Operation of Cell Medica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Cell Therapy Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Cell Therapy Sales Revenue Share, by Companies, in USD Million
Table Global Cell Therapy Sales Volume 2012-2017, by Companies, in Volume
Table Global Cell Therapy Sales Revenue Share, by Companies in 2017, in Volume
Table Cell Therapy Demand 2012-2017, by Application, in USD Million
Table Cell Therapy Demand 2012-2017, by Application, in Volume
Table Cell Therapy Demand Forecast 2018-2023, by Application, in USD Million
Table Cell Therapy Demand Forecast 2018-2023, by Application, in Volume
Table Global Cell Therapy Market 2012-2017, by Region, in USD Million
Table Global Cell Therapy Market 2012-2017, by Region, in Volume
Table Cell Therapy Market Forecast 2018-2023, by Region, in USD Million
Table Cell Therapy Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Cell Therapy Industry Chain Structure
Figure Global Cell Therapy Market Growth 2012-2017, by Type, in USD Million
Figure Global Cell Therapy Market Growth 2012-2017, by Type, in Volume
Figure Global Cell Therapy Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Cell Therapy Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Cell Therapy Industry Chain Structure
Figure Global Cell Therapy Market Growth 2012-2017, by Type, in USD Million
Figure Global Cell Therapy Market Growth 2012-2017, by Type, in Volume
Figure Global Cell Therapy Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Cell Therapy Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
